Organized by Sevgi Aral and James Blanchard

Speaker(s):

Talk 1. Phase-Specific Strategies for HIV and STI Control: Conceptual Development
- Sevgi Aral, Centers for Disease Control and Prevention, USA

Talk 2. Background and Progress in Phase-specific Strategies
- Judy Wasserheit, University of Washington, USA 

Talk 3. Emerging Research Methods and Collaborations to Improve Program Design and Implementation
- Geoff Garnett, Bill & Melinda Gates Foundation, USA

Talk 4. Appraising Epidemic Phases and Transmission Dynamics – Insights from Epidemiology and Mathematical Modeling
- Sharmistha Mishra, University of Toronto, Canada

Talk 5. Rethinking Approaches for Focusing Programs Based on Risk
- Stefan Baral, Johns Hopkins University, USA

Talk 6. Art-based Prevention: Observations on the Pathway from Efficacy to Effectiveness
- Myron Cohen, University of North Carolina, USA

Talk 7. How Can We Improve Resource Allocation and Management in the Changing Global HIV Landscape?
- David Wilson, World Bank, USA

Talk 8. HIV and STI Prevention Program Design: Back to the Basics
- James Blanchard, University of Manitoba, Canada

Talk 9. Challenges in the Implementation of New Interventions for HIV/STI
- Helen Ward, Imperial College London, UK

Talk 10. Phase Shifts in HIV and STI Epidemics in Sub-Saharan Africa: Implications for Programs and Science
- Richard Hayes, London School of Hygiene & Tropical Medicine, UK

Talk 11. Round Table Discussion - Phase Specific Strategies and Future Priorities for Program Science

Organized by University of California Los Angeles

Organized by Jen Balkus

Speaker(s):

08:00 - 08:15 Introductions and Motivations for the Vaginal Microbiome Laboratory Variability Project (MLVP)
- Jen Balkus, University of Washington, USA

08:15 - 08:30 Overview of the Vaginal Microbiome Laboratory Variability Project
- David Fredricks, Fred Hutchinson Cancer Research Center, USA

08:30 - 09:00 Laboratory challenges and Opportunities to Reduce Variability: Lessons Learned from the MLVP
- Sujatha Srinivasan, Fred Hutchinson Cancer Research Center, USA & Darrell Dinwiddie, University of New Mexico, USA

09:00 - 09:30 Bioinformatics Challenges and Opportunities to Reduce Variability: Lessons Learned from the MLVP
- Johanna Holm, University of Maryland & Liam Van Der Pol, University of Alabama, USA

09:30 - 10:00 Coffee break

10:00 - 10:20 Statistical Analyses and Challenges for Assessing Variability
- Jim Hughes, University of Washington, USA & Pawel Gajer, University of Maryland, USA

10:20 - 10:40 Successes and Challenges of Implementing the MLVP and Opportunities to Improve Reproducibility Moving Forward
- Jacques Ravel, University of Maryland, USA

10:40 - 11:20 Round Table Discussion with Other Experts Engaged in Vaginal Microbiome Research

Panel Discussion with

- Carolyn Deal (NIAID/DMID)

- Jennifer Fettweis (VCU)

- Doug Kwon (Ragon Institute)

- Deborah Money (UBC)

11:20 - 11:30 Wrap-up
- Jen Balkus, University of Washington, USA

Organized by Arlene C. Seña

Facilitators:

Laura Bachmann, MD, MPH - Medical Director, CDC Division of STD Prevention
Christine Johnson, MD, MPH - Associate Professor, University of Washington at Seattle; Medical Director, University of Washington STD Prevention Training Centers

Speaker(s):

Talk 1. Global STI Trends and Priorities for Antimicrobial Resistance
- Teodora Elvira Wi, MD
Medical Officer, STI Department of Reproductive Health and Research, World Health Organization

Talk 2. Pharmacokinetics and Pharmacodynamics – Factors to Consider for STI Treatment
- Jane Hocking, MD
Professor, Centre for Epidemiology and Biostatistics, Melbourne, Melbourne School of Population and Global Health, University of Melbourne

Talk 3. Resistance Emergence: Single vs Combination Therapies
- George L. Drusano, MD
Professor and Director, Institute for Therapeutic Innovation, University of Florida

Talk 4. Molecular Tests for Prediction of Antimicrobial Resistance (or Susceptibility) in N. gonorrhoeae and M. genitalium
- Magnus Unemo, PhD
Associate Professor, Director, WHO Collaborating Centre for Gonorrhoea and other STIs, Swedish Reference Laboratory for STIs, Örebro University Hospital, Sweden

Talk 5. Are We Ready for This? - Antimicrobial Stewardship for STIs
- Arlene C. Seña, MD, MPH
Associate Professor, Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill; Medical Director, Durham County Department of Public Health

Organized by David Lewis and Gwenda Hughes

Speaker(s):

Talk 1. Syphilis: A Historical Overview
- David Lewis, University of Sydney, Australia

Talk 2. Keynote Lecture: Pathogenesis and Natural History of Syphilis
- Sheila Lukehart, University of Washington, USA

Talk 3. The Application of Modern Technologies to the Goal of Syphilis Elimination
- Caroline Cameron, University of Victoria, Canada

Talk 4. What Can We Learn about Syphilis from Whole Genome Sequencing of Global Treponema pallidum Strains
- Nick Thompson, Sanger Institute, UK

Talk 5. Syphilis in the Context of HIV Co-infection
- Khalil Ghanem, Johns Hopkins University, USA

Talk 6. Syphilis, the Great Imitator: Unusual Case Presentations of Syphilis in Adults
- Somesh Gupta, All India Institute of Medical Sciences, India

Talk 7. Recent Trends in Syphilis in Women and Congenital Syphilis in Developed Countries: A Changing Epidemiology?
- Gwenda Hughes, Public Health England, UK

Talk 8. Drivers and Determinants for the Rising Incidence of Syphilis in Men-Who-Have-Sex-with-Men
- Kyle Bernstein, Centers for Disease Control and Prevention, USA

Talk 9. Responding to Syphilis in China: The Importance of Key Populations
- Xiang-Sheng Chen, National Center for STD Control, China

Talk 10. Syphilis Control Efforts and Public Health Policy: Global Perspectives
- Francis Ndowa, Skin & GU Medicine Clinic, Harare, Zimbabwe

Organized by Igor Toskin

Organized by Valeria Stuardo Ávila

Speaker(s):

Talk 1. The Ibero-American Network on Gay Men, Others MSM and Trans Studies
- Valeria Stuardo Ávila, Escuela de Salud Pública, Facultad de Medicina, Universidad de Chile, Santiago, Chile

Talk 2. Methods, Recruitment and Promotion of Latin American Men Who Have Sex With Men Internet Survey (LAMIS-2018)
- Carlos Cáceres, Centro de Investigación Interdisciplinaria en Sexualidad, SIDA y Sociedad, Universidad Peruana Cayetano Heredia, Lima, Peru
- Percy Fernandez-Davila, Centre d'Estudis Epidemiològics sobre lês Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT) - Stop SIDA Barcelona, Spain

Talk 3. General Results - Descriptive Analysis of LAMIS 2018: Implications for Collaborative Public Policies in the Latin American Region
- Jordi Casabona, Centre d'EstudisEpidemiològics sobrelesInfeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Barcelona, Spain

Talk 4. Online Survey Confirms High Rates of HIV Infection Among MSM in Brazil, Regardless of Their Level of Education
- Maria Amélia Veras, Faculdade de Ciências Médicas daSanta Casa de São Paulo, Núcleo de Pesquisa em Direitos Humanos e Saúde LGBT, Brazil

Organized by Okeoma Mmeje

Speaker(s):

Talk 1. Overview of Expedited Partner Therapy
- Okeoma Mmeje, University of Michigan, USA

Talk 2. Expedited Partner Therapy Use in Heterosexuals
- Jenell Coleman, Johns Hopkins University, USA

Talk 3. Expedited Partner Therapy Use in Adolescents & School-Based Clinics
- Nicole Speck, University of Michigan, USA

Talk 4. Support for Expedited Partner Therapy Use in Men Who Have Sex with Men & Transgender Women
- Kristi Gamarel, University of Michigan, USA
- Raha Richardson, University of Michigan, USA

Talk 5. Implications for Expedited Partner Therapy Use in Men Who Have Sex with Men
- Julia Schillinger, Centers for Disease Control and Prevention, USA

Organized by Ameeta Singh

Chair(s):

Max Chernesky, McMaster University, Canada
Margaret Gale-Rowe, PHAC, Canada

Speaker(s):

Talk 1. Mycoplasma genitalium
- Annie-Claude Labbe, Université de Montréal, Canada

Talk 2. Gonorrhea: Approach to Management in the Setting of Rising Antimicrobial Resistance
- Ameeta Singh, University of Alberta, Canada

Talk 3. Prenatal Screening for STBBIs
- Mark Yudin, University of Toronto, Canada

Organized by Jo-Anne Dillon & IUSTI-Canada

Organized by Leonard Foster

Speakers:

Talk 1. Metaproteomics for Discovering Mechanisms and Biomarkers in the Vaginal Microbiome
- Adam Burgener, University of Manitoba, Canada

Talk 2. Statistical Considerations for Clinical Trials Using Proteomics
- Speaker To Be Decided

Talk 3. When and How to Bring in Proteomics
- Leonard Foster, UBC, Canada

Talk 4. Practical Considerations for Moving Proteomic Tests into the Clinic
- Angela Fung, Clinical Chemist, St. Paul’s Hospital, Vancouver, Canada

Organized by the Sexually Transmitted Infections Vaccine Consortium, based in British Columbia (STRIVE-BC)

Speaker(s):

Opening Remarks
- Troy Grennan & Monika Naus, University of British Columbia & the BC Centre for Disease Control, Canada

Talk 1. The Current Landscape of STI Vaccines
- Carolyn Deal, National Institute of Allergy and Infectious Diseases, USA

Talk 2. STI Vaccine Roadmap
- Sami Gottlieb, World Health Organization, Switzerland

Talk 3. Will the World Accept STI Vaccines? Lessons from the HPV Vaccine
- Simon Dobson, University of British Columbia, Canada

Talk 4. STI Vaccine Development Updates: Current Science and Future Directions
- Syphilis: Caroline Cameron, University of Victoria, Canada
- Gonorrhea: Rino Rappuoli, GSK Vaccines, Italy
- Chlamydia: Kevin Hybiske, University of Washington, USA
- HSV: Anna Wald, University of Washington, USA

Talk 5. Priority Setting for Future Science & Research (Panel Discussion) 
- Moderated by: Scott Lamontagne, University of Washington, USA
- Caroline Cameron, University of Victoria, Canada
- Carolyn Deal, National Institute of Allergy and Infectious Diseases, USA
- Charu Kaushic, Canadian Institutes of Health Research, Canada
- Rino Rappuoli, GSK Vaccines, Italy
- Peter Dull, Bill & Melinda Gates Foundation

Talk 6. Implementation Challenges in Public Health (Panel Discussion) 
- Moderated by: Scott Lamontagne, University of Washington, USA
- Sami Gottlieb, World Health Organization, Switzerland
- Bonnie Henry, Government of British Columbia, Canada
- Manish Sadarangani, Vaccine Evaluation Centre, Canada
- Peter Dull, Bill & Melinda Gates Foundation

Closing Remarks
- Manish Sadarangani, Vaccine Evaluation Centre, Canada and Gina Ogilvie, School of Population and Public Health (SPPH), Canada

Organized by Igor Toskin

Workshop organising committee:

Dr Katy Turner, Prof Nicola Low, Dr Yonatan Grad, Prof Teodora Wi, Prof Magnus Unemo, Dr Minttu Ronn

The workshop will provide a cross-disciplinary approach to the challenge of antimicrobial resistant (AMR) bacteria causing sexually transmitted infections (STIs). Antimicrobial resistance is a complex challenge, most of the data and published work is focused on high income settings, but the main burden of disease due to drug resistance will occur in low and middle income (LMIC) countries. Please tweet from the workshop using the following hashtags.

#AMRSTI #ISSTDR2019 #IUSTIWorld2019

Speaker(s):

WHO perspectives on the threat of AMR – global challenges of surveillance
- Prof Teodora Wi

Epidemiological trends in AMR in Neisseria gonorrhoeae and implications for services
- Prof Nicola Low

Advances in genomic analysis and application to epidemiology of AMR in STIs
- Prof Yonatan Grad

Antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium
- Prof Magnus Unemo

Modelling the epidemiology of AMR in gonorrhoea
- Dr Katy Turner

Modelling vaccination as a way to control AMR
- Dr Laith Abu Raddad

Organized by Louise Jackson

Organized by Lisa McDaid

Chair(s): 

Lisa McDaid, University of Glasgow, UK

Speaker(s): 

Talk 1. Introduction to Contemporary Behavioural Surveillance
- Lisa McDaid, University of Glasgow, UK
- Nathan Lachowsky, University of Victoria, Canada

Talk 2. The Current State of Behavioural Surveillance (Panel Discussion) 
- Nathan Lachowsky, University of Victoria, Canada
- Patrick Sullivan, Emory University, USA
- Benjamin Bavinton, Kirby Institute, Australia
- Peter Saxton, University of Auckland, New Zealand
- Jamie Frankis, Glasgow Caledonian University, UK

Talk 3. Changing HIV Epidemics and Representativeness of Behavioural Surveillance Research (Panel Discussion) 
- Peter Saxton, University of Auckland, New Zealand
- Nathan Lachowsky, University of Victoria, Canada
- Jamie Frankis, Glasgow Caledonian University, UK

Talk 4. Why do We Still Need Behavioural Surveillance in the Age of Biomedical HIV Prevention? (Panel Discussion) 
- Benjamin Bavinton, Kirby Institute, Australia
- Jamie Frankis, Glasgow Caledonian University, UK
- Patrick Sullivan, Emory University, USA

Talk 5. Neglected Populations and Regions (Panel Discussion) 
- Jacqueline Gahagan, Dalhousie University, Canada
- Tyrone Curtis, University College London, UK
- Harlan Pruden, BC Centre for Disease Control, Canada

Talk 6. Biobehavioural Surveillance: The Challenges of Biological Sampling (Panel Discussion) 
- Patrick Sullivan, Emory University, USA
- Jamie Frankis, Glasgow Caledonian University, UK
- John Kim, Public Health Agency of Canada, Canada

Talk 7. Community Engagement in Behavioural Surveillance Research (Panel Discussion) 
- David Brennan, University of Toronto, Canada
- Jeff Morgan, CBRC - Community Based Research Centre for Gay Men’s Health, Canada
- Lisa McDaid, University of Glasgow, UK

Talk 8. Application of Theoretical Models to Periodic Behavioural Surveillance and What Is Missed If You Do Not Have One (Panel Discussion) 
- Paul Flowers, Glasgow Caledonian University, UK
- Kiffer Card, Simon Fraser University, Canada

Speaker(s):

Rino Rappuoli, GSK Vaccines, Italy

Speaker(s):

Helena Seth-Smith, University Hospital Basel, Switzerland

Speaker(s):

Christina Marra, University of Washington, USA

Speaker(s):

Charlotte Loppie, University of Victoria, Canada

Talk 1. Theoretical Overview on Methods Including RCTs and Other Potential Methodologies- Advantages and Disadvantages 
- Isolde Birdthistle, The London School of Hygiene & Tropical Medicine, UK 

Talk 2. Pop ART- Applying RCTs to the Real World - Opportunities and Challenges Faced in Implementing and Evaluating Large Scale RCTs 
- Richard Hayes, The London School of Hygiene & Tropical Medicine, UK

Talk 3. Using Multiple Data Sources for Programme Evaluation: Integration of Program Monitoring Data with Other Research Studies
- Banadakoppa Ramesh, University of Manitoba, Canada

Talk 4. Evaluating Complex Public Health Issue Violence - Understanding and Measuring Violence and Evaluating Violence Interventions- Lessons from STRIVE
- Lori Heise, Johns Hopkins University, USA

Talk 1. Latino MSM and Latina Transgender Women Drinking in New York
- Speaker TBD

Talk 2. The North American Overdose Crisis: How Structural Violence, Prohibition, and Stigma Have Paralyzed Our Response
- Mark Tyndall, BC Centre for Disease Control, Canada

Talk 3. To be confirmed

Talk 4. Chemsex and New STI/HIV Diagnoses Among Gay, Bisexual and Other Men Who Have Sex with Men Attending Sexual Health Clinics
- Aseel Hegazi, St George's University Hospital Foundation Trust, UK

Talk 1. Impact of HIV PrEP on Risk Compensation and STI Epidemiology – What Does the Evidence Show?
- Helen Ward, Imperial College London, UK

Talk 2. The Role of Oral-Anal Transmission in Persistence of Chlamydial Infection - Henry de Vries, University of Amsterdam, Netherlands

Talk 3. Sexual Transmission of N. meningitidis in MSM and Implications for Public Health
- Anna McNulty, Sydney Sexual Health Centre, Australia

Talk 4. Hepatitis C in HIV-Negative MSM – A Growing Concern?
- Axel J. Schmidt, London School of Hygiene and Tropical Medicine, UK

Talk 1. Resistance-Guided Therapy for M.genitalium: Impact of Diagnostic Resistance Assays on Practice and Policy
- Catriona Bradshaw, Central Clinical School, Monash University, Australia

Talk 2. Point of Care and Home Testing Opportunities: Implications for Quality Public Health Practice
- Patricia Dittus, Centers for Disease Control and Prevention, USA

Talk 3. Implementing Molecular Testing to Predict Neisseria gonorrhoeae Susceptibility in Clinical Practice
- Jeffrey D. Klausner, Fielding School of Public Health, USA

Talk 4. To be confirmed

Speaker(s):

Jørgen Jensen, Statens Serum Institut, Denmark

Speaker(s):

Tonia Poteat, University of North Carolina, USA

Speaker(s):

Geoff Garnett, Bill & Melinda Gates Foundation, USA

Talk 1. To be confirmed

Talk 2. Mobilising for Health and Rights: A History of Sex Worker Activism in India
- Smarajit Jana, Sonagachi Research and Training Institute, India

Talk 3. Mobilization and Empowerment of Sex Workers: Can Self-Help Groups Bring About Sustained Change?
- Primrose Matambandazo, CeSHHAR, Zimbabwe

Talk 4. #SaveSexy: A Gamified Approach to Harnessing the Power of Community Activism for HIV Testing Promotion
- Benedict Bernabe, Red Whistle, Philippines

Talk 1. Use of Cervical Explants to Study Gonococcal Pathogenesis
- Daniel Stein, University of Maryland, USA

Talk 2. T. pallidum in vitro Growth
- Steven Norris, University of Texas, USA

Talk 3. Pigtailed Macaque Model of STIs
- Dorothy Patton, University of Washington, USA

Talk 4. Chlamydia trachomatis, Trichomonas vaginalis and Treponema pallidum Infections in Macaques: Effects on Simian HIV Acquisition
- Sundaram Ajay Vishwanathan, Center for Disease Control and Prevention, USA

Talk 1. HIV Self-Testing at the STAR Project
- Maryam Shahmanesh, London’s Global University, UK

Talk 2. Syphilis Self-Testing: A Nationwide Pragmatic Study Among Men Who Have Sex with Men in China
- Cheng Wang, Southern Medical University, China

Talk 3. HPV Self-Collection in Peru
- Patricia Garcia, Universidad Peruana Cayetano Heredi, Peru

Talk 4. Empowerment and Approaches for Stigma Reduction: Implementation of HIV Self-Testing Among Female Sex Workers
- Catherine Oldenburg, University of California, USA

Speaker(s):

Wafaa El-Sadr, Columbia University, USA

Talk 1. Biomedical Considerations
- Jane Hocking, University of Melbourne, Australia

Talk 2. Modeling Considerations Related to Multi-Site Infection
- Ian Spicknall, Centers for Disease Control and Prevention, USA

Talk 3. Behavioural Considerations
- Catherine Mercer, University College London, UK

Talk 4. Programmatic Considerations
- Jeanne Marrazzo, University of Alabama, USA

Talk 1. Resurgent STIs in LMIC in Reproductive Age
- Connie Celum, University of Washington, USA

Talk 2. Building STD Clinical Infrastructure in LMIC – Role of General Vs. Specialized Infrastructure
- Ligang Yang, Southern Medical University, China 

Talk 3. Cervical Cancer Prevention in LMICS: Are We on the Path to Elimination?
- Megan Huchko, Duke University, USA

Talk 4. The Importance of Self-care Interventions to Reduce STIs
- Manjulaa Narasimhan, World Health Organization, Switzerland

Speaker(s):

Kevin Hybiske, University of Washington, USA

Speaker(s):

David Wilson, World Bank, USA

Speaker(s):

David Peters, Johns Hopkins University, USA

Talk 1. Gonorrhea
- Kate Seib, Griffith University, Australia

Talk 2. Non-Pathogenic Borrelia Expressing Treponema pallidum Antigens as a Novel Approach to Evaluate Syphilis Vaccine Candidates
- Lorenzo Giacani, University of Washington, USA

Talk 3. HPV Therapeutic Vaccine
- Connie Thimble, Johns Hopkins University, USA

Talk 4. Chlamydial Nanoparticle Vaccine
- Michael Starnbach, Harvard University, USA

Talk 1. HPV Screening – New Evidence and Current State of the Art
- Suzanne Garland, The Royal Women’s Hospital, Australia

Talk 2. Treatment of Bacterial Vaginosis: How, When and How Much?
- Caroline Mitchell, Harvard University, USA

Talk 3. Screening Women for Bacterial STIs: Should We Scale-back?
- Jonathan Ross, University of Birmingham, UK

Talk 4. Prematurity and STI – Value of Screening and Treatment
- Deborah Money, University of British Columbia, Canada

Talk 1. Sexual Contact Networks, STI Transmission and the Effectiveness of Interventions: Insights from Mathematical Modelling
- Christian Althaus, University of Bern, Switzerland

Talk 2. Use of Whole Genome Sequencing to Explore Transmission Between Sexual Networks in an STI Outbreak
- Helen Fifer, Public Health England, UK

Talk 3. Maximizing the Acceptability, Feasibility and Validity of Sexual Network Studies: Lessons from the Field
- Abby Norris Turner, Ohio State University, USA

Talk 4. The Role of Sexual Networks in the Global Spread of Antimicrobial-resistance Enteric Infections
- Nigel Field, University College London, UK

Speaker(s):

Johan Melendez, Johns Hopkins University, USA

Speaker(s):

Rena Janamnuaysook, The Thai Red Cross AIDS Research Centre, Thailand

Chair(s):

Kyle Bernstein, Centers for Disease Control and Prevention, USA

Speaker(s):

For the motion: Kit Fairley, Monash University, Australia

Against the motion: Hunter Handsfield, University of Washington, USA

Talk 1. Proteomics for T. pallidum
- Chris Kenyon, Institute of Tropical Medicine, Belgium

Talk 2. CRISPR Diagnostics: Expanding the Nucleic Acid Detection Toolbox by Harnessing Microbial Diversity
- Jonathan Gootenberg, Massachusetts Institute of Technology, USA

Talk 3. Reducing the global burden of infectious diseases through precision infection management (PIM)
- Ian Lewis, University of Calgary, Canada

Talk 4. Nanoparticle Delivery of Drugs to Mucosal Surfaces
- Kim Woodrow, University of Washington, USA

Talk 1. The Use of Existing Data to Plan HIV Prevention Activities in Zimbabwe
- Isaac Taramusi, National AIDS Council, Zimbabwe

Talk 2. Applications of the HIV Prevention Cascade Framework in Evaluating the DREAMS Program
- Maryam Shahmanesh, London’s Global University, UK

Talk 3. Application of a Cascade Approach of Guiding Prevention of Congenital Syphilis
- Patricia Garcia, Universidad Peruana Cayetano Heredia, Peru

Talk 4. Cascades and Other Approaches to Guide PrEP Programming
- Sinead Delany-Moretlwe, Wits Reproductive Health and HIV Institute, South Africa

Talk 1. Does Azithromycin Have a Future in the Treatment of Gonorrhoea and Chlamydial Infection?
- Jane Hocking, University of Melbourne, Australia

Talk 2. Should Enteric Infections in MSM Always Be Treated?
- Mark Pakianathan, St George’s University Hospital Foundation Trust, UK

Talk 3. Do Rectal Bacterial STIs in Women Matter? Who Should We Test and When?
- Christine Khosropour, University of Washington, USA

Talk 4. HPV Immunization in MSM: Who Should Be Immunized and Is There a Role for Immunization in Prevention
- David Templeton, University of Sydney, Australia 

Talk 1. An Update on the Status of HIV/STIs in IUSTI's Five Regions
- Francis Ndowa, Skin & GU Medicine Clinic, Harare, Zimbabwe

Talk 2. Bridging the Gap - Best Practice Global Examples of Integration of HIV and STI Services
- Janet Wilson, National Health Service, UK

Talk 3. Improving the Sexual and Reproductive Health of Women Living with HIV
- Angelica Espinosa Miranda, Universidade Federal do Espirito Santo, Brazil

Talk 4. Engaging Culturally and Linguistically Diverse Populations in HIV/STI Services: Challenges and Opportunities
- Shailendra Sawleshwarkar, University of Sydney, Australia

Talk 1. Perspectives from North America
- Karen Schlanger, Center for Disease Control and Prevention, USA

Talk 2. Perspectives from Brazil and Latin America
- Adele Schwartz Benzaken, Tropical Medicine Foundation, Manaus, Amazonas, Brazil

Talk 3. Perspectives from Thailand and Asia
- Pachara Sirivongrangson, Thailand Ministry of Public Health, Thailand

Talk 4. Gonorrhoea in EU/EEA - Disease Burden, Key Populations and Antimicrobial Resistance
- Otilia Mårdh, European Centre for Disease Prevention and Control (ECDC), Sweden

Talk 1. To be confirmed

Talk 2. Intersectionality, Criminalisation and Sexual Health
- Carmen Logie, University of Toronto, Canada

Talk 3. To be confirmed

Talk 4. To be confirmed

Talk 1. Youth and Community Based Research
- Sarah Flicker, York University, Canada

Talk 2. Addressing Anti-LGBT Stigma and Medical Mistrust through a Data-Informed Approach to Community Engagement
- Errol Fields, Johns Hopkins University, USA

Talk 3. Authentic and successful community engagement for STI/HIV prevention, screening, and treatment in rural and urban settings
- Scott Rhodes, University of North Carolina, USA

Talk 4. To be confirmed

Speaker(s):

Charlotte Watts, UK Department of International Development (DFID), UK